Finerenone in patients with chronic kidney disease and type 2 diabetes, with and without a history of heart failure: a secondary analysis of the FIDELIO-DKD trial

29 June 2021 (17:20 - 17:40)
Organised by:
Congress Presentation Part of: Late-Breaking Trials 1 Clinical HFA Premium Access Heart Failure 2021

ESC 365 is supported by

ESC 365 is supported by